# Baxalta US Inc. – FDA Inspection, Jan 17, 2020

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/1e6d6d48-82cf-4812-9ae5-37c4ede74bed
Source feed: FDA_Inspections

> FDA inspection 1118072 of Baxalta US Inc., January 17, 2020. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118072
- Company Name: Baxalta US Inc.
- Inspection Date: 2020-01-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1279237 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/95291689-7d92-4668-a518-7c2443655647)
- [FDA Inspection 1166545 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/0a393ccc-bf48-4160-8b4c-45d96b6b62fb)
- [FDA Inspection 1038757 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/67db9420-6ce8-4bd7-a8b9-1dfa5e54a11d)
- FDA Inspection 972505 - 2016-03-10
- FDA Inspection 870344 - 2014-02-28

Company: https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
